Hematology Fellows and Junior Faculty Participate in 2018 ASH Clinical Research Training Institute in Latin America
(WASHINGTON, April 24, 2018) — The American Society of Hematology (ASH) has announced the names of the 35 hematologists participating in the 2018 ASH Clinical Research Training Institute in Latin America (CRTI-LA) and Advanced CRTI-LA. This education and mentorship program will be held between April 23 and 26 in Rio de Janeiro, Brazil, prior to the Society’s Highlights of ASH in Latin America meeting.
CRTI-LA is a two-day program designed to prepare hematology fellows and junior faculty members working in Latin America for careers in clinical research. During that time, ASH member experts from around the world will introduce participants to the fundamentals of clinical trial design through educational sessions on topics such as biostatistics, developing clinical research questions, and writing an abstract and manuscript for publication.
Advanced CRTI-LA is a one-and-a-half-day workshop that provides ongoing training and mentorship for graduates of CRTI-LA. It focuses on continuing to educate and strengthen the clinical trial design and execution skills gained from previous participation in CRTI-LA.
“This program provides trainees in Latin America with a unique opportunity to learn best practices in clinical trial design that they can take away and apply to accelerating research in the region,” said ASH President Alexis Thompson, MD, MPH, of Ann & Robert H. Lurie Children’s Hospital of Chicago. “Supporting the careers of these talented fellows and junior faculty members, in this instance by guiding them from clinical trial design to implementation, is a priority for ASH.”
The 2018 CRTI-LA participants are:
Recipients | Institutions |
Maria Beltran Saez, MD, MSc | Hospital del Salvador, Región Metropolitana, Chile |
Maria Cecilia Bertone, MD | Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina |
María Bove, MD | Hospital de Clínicas, Montevideo, Uruguay |
Marcela Cavalcante de Andrade Silva, MD | Hospital Universitário Prof. Alberto Antunes (HUPPA/UFAL), Alagoas, Brazil |
María Clavijo, MD | Hospital Aleman, Buenos Aires, Argentina |
Pedro de Lima Prata, MD | Universidade de São Paulo, São Paulo, Brazil |
Roberta Demichelis, MD | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico |
Yurany Duarte Torres, MD | Bacterióloga y Laboratorista Clínico, Bogotá, Colombia |
David Duran Rodriguez, MD | Hospital Civil De Guadalajara, La Libertad, El Salvador |
Daniel Enriquez, MD | Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru |
Felix Gaytan-Morales, MD, MSc | Hospital Infantil de Mexico, Ciudad de Mexico, Mexico |
Katia Pagnano, MD, PhD | University of Campinas, São Paulo, Brazil |
Carla Pennella, MD | Hospital Juan P. Garrahan, Buenos Aires, Argentina |
Maria Perusini, MD | Hospital Italiano Buenos Aires, Buenos Aires, Argentina |
Luisina Peruzzo, MD | Hospital Juan P. Garrahan, Buenos Aires, Argentina |
Mariela Rodríguez, MD | Caja Costarricense del Seguro Social, San Jose, Costa Rica |
Wellington Silva Junior, MD | Universidade de São Paulo, São Paulo, Brazil |
Fabiola Traina, MD, PhD | Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, São Paulo, Brazil |
Thelma Velasquez Herrera, MD | Unidad Nacional de Oncologia Pediatrica, Guatemala, Guatemala |
2018 Advanced CRTI-LA Participants:
Recipients | Institutions |
Lucas Arruda, PharmD, PhD | Karolinska Institute, Stockholm, Sweden |
Christianne Bourlon De Los Rios MD, MHSc | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico |
Erika Brulc, MD | Hospital Italiano de Buenos Aires, Buenos Aires, Argentina |
Perla Rocío Colunga Pedraza, MD | Servicio de Hematología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Nuevo León, Mexico |
André Dias Américo, MD | Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Brazil |
Laura Fogliato, MD | Hospital de Clinicas de Porto Alegre Rio Grande do Sul Brazil |
Andres Gomez-De Leon, MD | Universidad Autonoma de Nuevo Leon. Facultad de Medicina y Hospital Universitario "Dr. José E González", Nuevo Leon, Mexico |
Victoria Maria Irigoín, MD | Hospital de Clinicas, Montevideo, Uruguay |
Mariana Kerbauy, MD | Hospital Israelita Albert Einstein, Sao Paulo, Brazil |
Laura Korin, MD | Fleming Institute, Buenos Aires, Argentina |
Marcelo Lacerda, MD | Universidade Federal de São Paulo, Sao Paulo, Brazil |
Elena Lisott, MD | Complejo Asistencial Victor Rios Ruiz, Chile |
Angela Trujillo, MD | Instituto de Cancerología Las Americas, Antioquia, Colombia |
Edvan Crusoe, MD, MSc, PhD | University Hospital -Federal University of Bahia, Bahia, Brazil |
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
Contact:
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925